Long-term pantoprazole trial in patients with symptoms of chronic acid peptic complaints.

Trial Profile

Long-term pantoprazole trial in patients with symptoms of chronic acid peptic complaints.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Jun 2013

At a glance

  • Drugs Pantoprazole (Primary)
  • Indications Gastric disorders; Gastro-oesophageal reflux; Peptic ulcer
  • Focus Adverse reactions
  • Sponsors Altana Group; Takeda Pharmaceuticals International GmbH
  • Most Recent Events

    • 22 Oct 2012 Results were published in Alimentary Pharmacology and Therapeutics in April 2012, and were reported briefly in a Takeda Pharmaceuticals media release.
    • 04 May 2012 Additional company (Takeda Global Research and Development Center) added in association as reported by ClinicalTrials.gov.
    • 08 Jan 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top